Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Cytek Biosciences (CTKB) Shares Repurchased (2023 - 2025)

Cytek Biosciences (CTKB) has disclosed Shares Repurchased for 3 consecutive years, with -$8000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Repurchased fell 100.11% year-over-year to -$8000.0, compared with a TTM value of $15.1 million through Dec 2025, down 30.16%, and an annual FY2025 reading of $15.1 million, down 30.13% over the prior year.
  • Shares Repurchased was -$8000.0 for Q4 2025 at Cytek Biosciences, up from -$29000.0 in the prior quarter.
  • Across five years, Shares Repurchased topped out at $34.6 million in Q4 2023 and bottomed at -$29000.0 in Q3 2025.
  • Average Shares Repurchased over 3 years is $8.9 million, with a median of $7.0 million recorded in 2024.
  • Peak annual rise in Shares Repurchased hit 69.93% in 2025, while the deepest fall reached 100.24% in 2025.
  • Year by year, Shares Repurchased stood at $34.6 million in 2023, then crashed by 79.77% to $7.0 million in 2024, then crashed by 100.11% to -$8000.0 in 2025.
  • Business Quant data shows Shares Repurchased for CTKB at -$8000.0 in Q4 2025, -$29000.0 in Q3 2025, and $4.5 million in Q2 2025.